Daclizumab trial for relapsing-remitting MS begins

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Daclizumab trial for relapsing-remitting MS begins

Postby MSUK » Mon May 24, 2010 6:25 am

Image

Active Comparator Study Designed to Examine the Safety and Efficacy of Daclizumab Formulated for Monthly Subcutaneous Dosing.

Biogen Idec and Abbott today announced enrollment of the first patient in a global Phase III study evaluating the efficacy and safety of daclizumab compared to to interferon beta-1a (Avonex(R)) in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS).. [Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1502]
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2105
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Postby ssmme » Mon May 24, 2010 9:39 am

It appears that this drug is to be taken monthly along with the weekly, every other day, or every three day interferon shots. It's a disappointment that it doesn't replace them.
Marcia
User avatar
ssmme
Family Elder
 
Posts: 351
Joined: Sat Sep 22, 2007 3:00 pm
Location: Lexington, KY


Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users